Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer
Recruiting
This is a single arm phase II trial combination of ivonescimab and carbo-docetaxel every 3 weeks for 6 cycles in patients with early-stage triple negative breast cancer. The trial is designed to test the safety and efficacy of adding ivonescimab in patients with early TNBC undergoing neoadjuvant chemotherapy with carboplatin and docetaxel. Patients will receive ivonescimab 20 mg/kg IV on Day 1 of each cycle, and carboplatin AUC6 and docetaxel 75 mg/m2 on Day 1 of each cycle for 6 cycles. Cycles... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/18/2025
Locations: Cedars-Sinai Medical Center, Los Angeles, California +3 locations
Conditions: TNBC, TNBC - Triple-Negative Breast Cancer, Early Stage Triple-Negative Breast Carcinoma
Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD
Recruiting
Anxiety disorders in children and adolescents are common and confer significant disability. Cognitive behavioral therapy (CBT) is the recommended treatment for youth with anxiety, yet many families cannot access CBT due to cost, practicalities of attending in-person treatment sessions, and a shortage of trained providers, especially in rural areas. To combat these barriers, other treatment methods have been developed. Previous research has shown that family-based, internet-delivered CBT (iCBT)... Read More
Gender:
ALL
Ages:
Between 7 years and 17 years
Trial Updated:
07/18/2025
Locations: Baylor College of Medicine, Houston, Texas
Conditions: Obsessive Compulsive Disorder (OCD), Anxiety Disorder of Childhood or Adolescence, Social Anxiety Disorder of Childhood, Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder, Panic Disorder, Panic Attacks, Panic Disorder (With or Without Agoraphobia), Phobia, Specific
The Impact of Deep Brain Stimulation on Speech and Swallow Function in Parkinson Disease
Recruiting
Nearly one-million people in North America are now living with Parkinson's disease (PD), and that number is projected to rise to nearly 1.2 million by 2030. With advancements in neuromodulatory technologies, increasingly more of these individuals elect to undergo deep brain stimulation (DBS) surgery in order to control symptoms of the disease, including refractory tremor, medication-induced dyskinesias, and PD-associated dystonia. The two most common DBS neural targets for controlling these symp... Read More
Gender:
ALL
Ages:
Between 45 years and 85 years
Trial Updated:
07/18/2025
Locations: University of Florida, Norman Fixel Institute for Neurological Diseases, Gainesville, Florida
Conditions: Parkinson Disease, Idiopathic
Developing a Music Listening mHealth Intervention for Stress Reduction in Early Recovery
Recruiting
The overarching goal of this study is to develop and examine the feasibility of a music-listening intervention that can be deployed in "real time" to regulate emotions and reduce momentary stress among young adults within the first 12 months of recovery from alcohol use disorder. We design the study with two phases to address three aims: Phase I includes the first two aims. For Aim 1, we will conduct formative research with a sample of young adults (N = 30) who have are within 12 months of recov... Read More
Gender:
ALL
Ages:
Between 18 years and 35 years
Trial Updated:
07/18/2025
Locations: Washington State University Research Clinic, Spokane, Washington
Conditions: Alcohol Use Disorder (AUD)
Seminar in Unwavering Empowering Presence Optimized for Rehabilitation Teams
Recruiting
The goal of this study to test the feasibility, acceptability, and potential impact of a serious illness communication skills training (CST) tailored to rehabilitation professionals to improve their comfort and confidence in navigating difficult conversations with patients and families. Primary Objectives: Aim 1: To assess feasibility and acceptability of a multidisciplinary co-designed interactive CST program for rehabilitation professionals who care for children with serious illness and thei... Read More
Gender:
ALL
Ages:
All
Trial Updated:
07/18/2025
Locations: St. Jude Children's Research Hospital, Memphis, Tennessee
Conditions: Communication
Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
Recruiting
The purpose of this study is to compare the safety and efficacy of letermovir with valganciclovir for prevention of Cytomegalovirus (CMV) viremia in moderate to high risk serostatus heart transplant recipients.
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
07/18/2025
Locations: NYP-Weill Cornell, New York, New York +1 locations
Conditions: CMV Viremia, Heart Transplant Infection, Heart Transplant Failure and Rejection
A Neurosensory Account of Anxiety and Stress
Recruiting
This study will take a basic neuroscience approach to investigate pathological mechanisms underlying PTSD. Additionally, the study aims to identify how Transcranial Alternating Current Stimulation (tACS) brain stimulation can modulate and correct neural networks and related emotions of anxious arousal and hypervigilance, with the goal of assessing tACS brain stimulation technology as a novel intervention for symptoms of anxiety.
Gender:
ALL
Ages:
Between 18 years and 50 years
Trial Updated:
07/18/2025
Locations: The University of Texas Health Science Center at Houston, Houston, Texas
Conditions: Threat-related Sensory Cortical (SC) Disinhibition, Posttraumatic Stress Disorder (PTSD)
Methamphetamine Cue-reactivity
Recruiting
In this observational cohort study, the researchers propose to first identify a psychophysiological marker of methamphetamine cue-reactivity and its incubation with abstinence from methamphetamine use (MUD) and examine group-differences between men who have sex with men (MSM) and non-MSM MUD. The primary objective is to identify psychophysiological markers of methamphetamine (MA) cue-reactivity and its abstinence incubation. The secondary objective is to examine group-differences in methampheta... Read More
Gender:
MALE
Ages:
Between 18 years and 60 years
Trial Updated:
07/18/2025
Locations: Icahn School of Medicine at Mount Sinai, New York, New York
Conditions: Methamphetamine Use Disorder
Resources for Optimizing Outcomes in Toddlers on the Spectrum
Recruiting
The goal of this clinical trial is to assess whether telehealth-based Family Navigation (FN) expedites enrollment (e.g., reduces time in days) in community-based autism intervention for toddlers under the age of 4 living in Rural NC after their initial diagnosis of autism. The main questions it aims to answer are: Does Family Navigation decrease the time to initiation of intervention for rural toddlers with autism? Does Family Navigation improve developmental outcomes at 18 months post-diagno... Read More
Gender:
ALL
Ages:
Between 1 year and 99 years
Trial Updated:
07/18/2025
Locations: Carolina Institute for Developmental Disabilities, Carrboro, North Carolina
Conditions: Autism Spectrum Disorder
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
Recruiting
This is a prospective, observational study evaluating whether heart sounds (phonocardiograms) and three-lead electrocardiograms (ECGs) recorded using the Eko CORE 500 digital stethoscope can help detect pulmonary hypertension (PH) and low left ventricular ejection fraction (EF ≤ 40%). PH is a condition characterized by high blood pressure in the pulmonary arteries, which can lead to heart failure and carries significant risks if undiagnosed. Low EF, which indicates reduced pumping ability of the... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/18/2025
Locations: Prairie Cardiovascular, O'Fallon, Illinois +2 locations
Conditions: Hypertension, Pulmonary, Heart Failure With Reduced Ejection Fraction
Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
Recruiting
The purpose of this study is to investigate possible genetic factors that contribute to the development of lymphomas. The databank will be used to determine whether familial lymphomas have unique genetic characteristics different from sporadic lymphomas and to attempt to identify a gene that confers an increased risk of lymphoma.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/17/2025
Locations: Dana-Farber Cancer Institute, Boston, Massachusetts
Conditions: Non-Hodgkin's Lymphoma, Hodgkin's Disease, Leukemia, Lymphocytic, Chronic, Lymphoproliferative Disorders
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Recruiting
22q11.2 deletion syndrome is a genetic disorder that can cause heart defects, facial abnormalities, and developmental and learning disabilities. The severity of the disorder can vary widely among people. This study will analyze DNA from people with 22q11.2 deletion syndrome to identify genetic variations that may affect the severity of the disorder.
Gender:
ALL
Ages:
All
Trial Updated:
07/17/2025
Locations: Albert Einstein College of Medicine, New York, New York
Conditions: DiGeorge Syndrome, 22q11.2 Deletion Syndrome